Effects of underlying heart failure on outcomes of COVID-19; a systematic review and meta-analysis

被引:3
|
作者
Morsali, Soroush [1 ]
Rezazadeh-Gavgani, Erfan [1 ]
Oladghaffari, Mobina [1 ]
Bahramian, Shirin [1 ]
Hamzehzadeh, Sina [1 ]
Samadifar, Zahra [2 ]
Enamzadeh, Elgar [2 ]
Sheikhalipour, Zahra [3 ]
Moradi, Haniyeh [1 ]
Pourmehr, Hanieh Salehi [3 ]
Naseri, Amirreza [1 ]
Taban-Sadeghi, Mohammadreza [2 ]
Daneshvar, Sara [1 ]
机构
[1] Tabriz Univ Med Sci, Student Res Comm, Tabriz, Iran
[2] Tabriz Univ Med Sci, Cardiovasc Res Ctr, Tabriz, Iran
[3] Tabriz Univ Med Sci, Iranian EBM Ctr Joanna Briggs Inst Ctr Excellence, Res Ctr Evidence Based Med, Tabriz, Iran
关键词
COVID-19; Heart Failure; Mechanical Ventilation; Mortality; Comorbidity; IMPACT;
D O I
10.2478/rjim-2022-0021
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: The risk for worse outcomes of COVID-19 (Coronavirus 2019 disease), is higher in patients with cardiac conditions. In this study, we aim to investigate the risks of COVID-19-induced conditions in cases with underlying heart failure. Methods: We systematically searched PubMed, Scopus, Ovid, ProQuest, Web of Science, and the Cochrane library, to collect the English language articles that investigated patients with underlying heart failure who get infected by COVID-19. The second version of comprehensive meta-analysis (CMA.2) software was used to conduct the meta-analysis. Results: From 5997 publications, our eligibility criteria were met by 27 studies. Overall, outcomes investigated in all studies include but are not limited to mortality rate, length of hospitalization, need for Intensive care unit (ICU) admission, need for mechanical ventilation, and major cardiovascular conditions. Regarding mortality heart failure patients were more susceptible to death (OR:2.570, 95%CI: 2.085 to 3.169; p-value:< 0.001). Also in heart failure patients, the risk of mechanical ventilation was higher (OR:1.707, 95%CI: 1.113 to 2.617; p-value: 0.014). Conclusion: Pre-existing heart failure is associated with the increased risk of mortality and the need for mechanical ventilation while getting infected with COVID-19. Finding an answer to determine the risk of hospitalization, length of stay, readmission rate, and multiorgan failure is necessary for further development of preventive care and making a plan for providing optimal healthcare facilities for these patients.
引用
收藏
页码:6 / 27
页数:22
相关论文
共 50 条
  • [21] CLINICAL OUTCOMES OF REMDESIVIR IN COVID-19: A SYSTEMATIC REVIEW AND META-ANALYSIS
    Gupta, Ishita
    Mahapure, Kiran
    Bansal, Vikas
    Hassanain, Sahar
    Makadia, Janaki
    Madas, Nimisha
    Armaly, Paige
    Singh, Romil
    Mehra, Ishita
    Bhurwal, Abhishek
    Kashyap, Rahul
    CRITICAL CARE MEDICINE, 2021, 49 (01) : 57 - 57
  • [22] The impact of ivermectin on COVID-19 outcomes: a systematic review and meta-analysis
    Yengu, Nithin Sai
    Raheem, Abdul
    Pons, Andrea Gomez
    Ho, Wing Lam
    Ali, Syed Muhammad Sinaan
    Haseeb, Abdul
    Ahmad, Tagwa Kalool Fadlalla
    Mustafa, Muhammad Saqlain
    ANNALS OF MEDICINE AND SURGERY, 2025, 87 (02): : 809 - 829
  • [23] Biomarkers and outcomes of COVID-19 hospitalisations: systematic review and meta-analysis
    Malik, Preeti
    Patel, Urvish
    Mehta, Deep
    Patel, Nidhi
    Kelkar, Raveena
    Akrmah, Muhammad
    Gabrilove, Janice L.
    Sacks, Henry
    BMJ EVIDENCE-BASED MEDICINE, 2021, 26 (03) : 107 - +
  • [24] Effects of Vitamin D Supplementation on COVID-19 Related Outcomes: A Systematic Review and Meta-Analysis
    Hosseini, Banafsheh
    El Abd, Asmae
    Ducharme, Francine M.
    NUTRIENTS, 2022, 14 (10)
  • [25] Prevalence of Underlying Diseases in Hospitalized Patients with COVID-19: a Systematic Review and Meta-Analysis
    Emami, Amir
    Javanmardi, Fatemeh
    Pirbonyeh, Neda
    Akbari, Ali
    ARCHIVES OF ACADEMIC EMERGENCY MEDICINE, 2020, 8 (01)
  • [26] Prevalence of underlying diseases in died cases of COVID-19: A systematic review and meta-analysis
    Javanmardi, Fatemeh
    Keshavarzi, Abdolkhalegh
    Akbari, Ali
    Emami, Amir
    Pirbonyeh, Neda
    PLOS ONE, 2020, 15 (10):
  • [27] The effects of aspirin on the outcome of COVID-19: A systematic review and meta-analysis
    Wijaya, Indra
    Andhika, Rizky
    Huang, Ian
    Purwiga, Aga
    Budiman, Kevin Yonatan
    CLINICAL EPIDEMIOLOGY AND GLOBAL HEALTH, 2021, 12
  • [28] Effects of pharmacist interventions on heart failure outcomes: A systematic review and meta-analysis
    Arunmanakul, Poukwan
    Kengkla, Kirati
    Chaiyasothi, Thanaputt
    Phrommintikul, Arintaya
    Ruengorn, Chidchanok
    Permsuwan, Unchalee
    Thakkinstian, Ammarin
    Page, Robert L., II
    Munger, Mark A.
    Nathisuwan, Surakit
    Chaiyakunapruk, Nathorn
    JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY, 2021, 4 (07): : 871 - 882
  • [29] Outcomes among patients with COVID-19 and asthma A systematic review and meta-analysis
    Sitek, Andrea N.
    Ade, Justine M.
    Chiarella, Sergio E.
    Divekar, Rohit D.
    Pitlick, Mitchell M.
    Iyer, Vivek N.
    Wang, Zhen
    Joshi, Avni Y.
    ALLERGY AND ASTHMA PROCEEDINGS, 2021, 42 (04) : 267 - 273
  • [30] Outcomes of STEMI Patients in COVID-19 Pandemic: A Systematic Review and Meta-Analysis
    Khaleghparast, Shiva
    Maleki, Majid
    Noohi, Fereidoun
    Fathollahi, Mahmood Sheikh
    Khalili, Yasaman
    Pasebani, Yeganeh
    Rafiee, Farnaz
    Farrokhzadeh, Fahimeh
    Biglari, Sajjad
    Mazloomzadeh, Saeideh
    IRANIAN JOURNAL OF PUBLIC HEALTH, 2024, 53 (09) : 1964 - 1975